FMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependence

Psychiatry Research - Neuroimaging

Volumn 192, Issue 3, 2011, Pages 167-175

  Meade, Christina S ^a,b,c   Lowen, Steven B ^b,c   MacLean, Robert R ^b   Key, Mary D ^a   Lukas, Scott E ^b,c  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCLEAN HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cocaine dependence; Decision making; Delay discounting; Functional magnetic resonance imaging; HIV AIDS

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANTERIOR CINGULATE; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DECISION MAKING; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; ORBITAL CORTEX; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; BRAIN; BRAIN MAPPING; CHI-SQUARE DISTRIBUTION; CHOICE BEHAVIOR; COCAINE-RELATED DISORDERS; DECISION MAKING; FEMALE; HIV SEROPOSITIVITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OXYGEN; QUESTIONNAIRES; TIME FACTORS; YOUNG ADULT;

EID: 79955971759     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2010.12.011     Document Type: Article

References (66)

1. Ainslie G. Specious reward: a behavioral theory of impulsiveness and impulse control. Psychological Bulletin 1975, 82:463-496.
2. Anthony I.C., Bell J.E. The neuropathology of HIV/AIDS. International Review of Psychiatry 2008, 20:15-24.
3. Arnsten J.H., Demas P.A., Grant R.W., Gourevitch M.N., Farzadegran H., Howard A.A., Schoenbaum E.E. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine 2002, 17:377-381.
4. Aron J.L., Paulus M.P. Location, location: using functional magnetic resonance imaging to pinpoint brain differences relevant to stimulant use. Addiction 2007, 102(Suppl 1):33-43.
5. Baum M.K., Rafie C., Lai S., Sales S., Page B., Campa A. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. Journal of Acquired Immune Deficiency Syndrome 2009, 50:93-99.
6. Bing E.G., Burnam M.A., Longshore D., Fleishman J.A., Sherbourne C.D., London A.S., Turner B.J., Eggan F., Beckman R., Vitiello B., Morton S.C., Orlando M., Bozzette S.A., Ortiz-Barron L., Shapiro M. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry 2001, 58:721-728.
7. Brew B.J. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 2004, 18(Suppl 1):75-78.
8. Chang L., Speck O., Miller E.N., Braun J., Jovicich J., Koch C., Itti L., Ernst T. Neuronal correlates of attention and working memory deficits in HIV patients. Neurology 2001, 57:1001-1007.
9. Chang L., Tomasi D., Yakupov R., Lozar C., Arnold S., Caparelli E., Ernst T. Adaptation of the attention network in human immunodeficiency virus brain injury. Annals of Neurology 2004, 56:259-272.
10. Coffey S.F., Gudleski G.D., Saladin M.E., Brady K.T. Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals. Experimental and Clinical Psychopharmacology 2003, 11:18-25.
11. Cole M.W., Schneider W. The cognitive control network: integrated cortical regions with dissociable functions. NeuroImage 2007, 37:343-360.
12. Cook J.A., Grey D.D., Burke-Miller J.K., Cohen M.H., Vlahov D., Kapadia F., Wilson T.E., Cook R., Schwartz R.M., Golub E.T., Anastos K., Ponath C., Goparaju L., Levine A.M. Illicit drug use, depression and their association with highly active antiretroviral therapy in HIV-positive women. Drug and Alcohol Dependence 2007, 89:74-81.
13. Cook J.A., Burke-Miller J.K., Cohen M.H., Cook R.L., Vlahov D., Wilson T.E., Golub E.T., Schwartz R.M., Howard A.A., Ponath C., Plankey M.W., Levine A.M., Grey D.D. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS 2008, 22:1355-1363.
14. Cysique L.A., Brew B.J. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychology Review 2009, 19:169-185.
15. Ernst T., Chang L.J., James N., Arnold S. Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology 2002, 59:1343-1349.
16. Ernst T., Yakupov R., Nakama H., Crocket G., Cole M., Watters M., Ricardo-Dukelow M.L., Chang L. Declined neural efficiency in cognitively stable human immunodeficiency virus patients. Annals of Neurology 2009, 65:316-325.
17. Ersche K.D., Fletcher P.C., Lewis S.J., Clark L., Stocks-Gee G., London M., Deakin J.B., Robbins T.W., Sahakian B.J. Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals. Psychopharmacology 2005, 180:612-623.
18. Farinpour R., Martin E.M., Seidenberg M., Pitrak D.L., Pursell K.J., Mullane K.M., Novak R.M., Harrow M. Verbal working memory in HIV-seropositive drug users. Journal of the International Neuropsychological Society 2000, 6:548-555.
19. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient/Non-patient Edition. Biometrics Research 1996, New York State Psychiatric Institute, New York.
20. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
21. Gonzalez R., Vassileva J., Bechara A., Grbesic S., Sworowski L., Novak R.M., Nunnally G., Martin E.M. The influence of executive functions, sensation seeking, and HIV serostatus on the risky sexual practices of substance-dependent individuals. Journal of the International Neuropsychological Society 2005, 11:121-131.
22. Grassi B., Garghentini G., Campana A., Grassi E., Bertelli S., Cinque P., Epifani M., Lazzarin A., Scarone S. Spatial working memory in asymptomatic HIV-infected subjects. Journal of Neuropsychiatry and Clinical Neurosciences 1999, 11:387-391.
23. Hardy D.J., Hinkin C.H., Levine A.J., Castellon S.A., Lam M.N. Risky decision making assessed with the gambling task in adults with HIV. Neuropsychology 2006, 20:355-360.
24. Harzke A.J., Williams M.L., Bowen A.M. Binge use of crack cocaine and sexual risk behaviors among African-American, HIV-positive users. AIDS and Behavior 2009, 13:1106-1118.
25. Hayaki J., Anderson B., Stein M. Sexual risk behaviors among substance users: relationship to impulsivity. Psychology of Addictive Behaviors 2006, 20:328-332.
26. Heaton R.K., Grant I., Butters N., White D.A., Kirson D., Atkinson J.H., McCutchan J.A., Taylor M.J., Kelly M.D., Ellis R.J., et al. The HNRC 500-neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. Journal of the International Neuropsychological Society 1995, 1:231-251.
27. Heil S.H., Johnson M.W., Higgins S.T., Bickel W.K. Delay discounting in currently using and currently abstinent cocaine-dependent outpatients and non-drug-using matched controls. Addictive Behaviors 2006, 31:1290-1294.
28. Hernstein R.J. Self control as response strength. Quantification of Steady State Operant Behavior 1981, 3-20. Elsevier/North Holland Biomedical Press, Amsterdam. C.M. Bradshaw, E. Szabadi, C.F. Lowe (Eds.).
29. Hinkin C.H., Barclay T.R., Castellon S.A., Levine A.J., Durvasula R.S., Marion S.D., Myers H.F., Longshore D. Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior 2007, 11:185-194.
30. Hoffman W.F., Moore M., Templin R., McFarland B., Hitzemann R.J., Mitchell S.H. Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psychopharmacology 2006, 188:162-170.
31. Hoffman W.F., Schwartz D.L., Huckans M.S., McFarland B.H., Meiri G., Stevens A.A., Mitchell S.H. Cortical activation during delay discounting in abstinent methamphetamine dependent individuals. Psychopharmacology 2008, 201:183-193.
32. Hult B., Chana G., Masliah E., Everall I. Neurobiology of HIV. International Review of Psychiatry 2008, 20:3-13.
33. Kampman K.M., Alterman A.I., Volpicelli J.R., Maany I., Muller E.S., Luce D.D., Mulholland E.M., Jawad A.F., Parikh G.A., Mulvaney F.D., Weinrieb R.M., O'Brien C.P. Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychology of Addictive Behaviors 2001, 15:52-59.
34. Kieburtz K., Ketonen L., Cox C., Grossman H., Holloway R., Booth H., Hickey C., Feigin A., Caine E.D. Cognitive performance and regional brain volume in human immunodeficiency virus type 1 infection. Archives of Neurology 1996, 53:155-158.
35. Kirby K.N., Petry N.M. Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls. Addiction 2004, 99:461-471.
36. Kirby K.N., Petry N.M., Bickel W.K. Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. Journal of Experimental Psychology: General 1999, 128:78-87.
37. Korthuis P.T., Zephyrin L.C., Fleishman J.A., Saha S., Josephs J.S., McGrath M.M., Hellinger J., Gebo K.A. Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care and STDs 2008, 22:859-867.
38. Kumar A.M., Borodowsky I., Fernandez B., Gonzalez L., Kumar M. Human immunodeficiency virus type 1 RNA levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction. Journal of Neurovirology 2007, 13:210-224.
39. Kuo W.H., Wilson T.E., Weber K.M., Madhava V., Richardson J., Delapenha R., Des Jarlais D. Initiation of regular marijuana use among a cohort of women infected with or at risk for HIV in the Women's Interagency HIV Study (WIHS). AIDS Patient Care and STDs 2004, 18:702-713.
40. Lejuez C.W., Simmons B.L., Aklin W.M., Daughters S.B., Dvir S. Risk-taking propensity and risky sexual behavior of individuals in residential substance use treatment. Addictive Behaviors 2004, 29:1643-1647.
41. Lejuez C.W., Bornovalova M.A., Daughers S.B., Curtin J.J. Differences in impulsivity and sexual risk behavior among inner-city crack/cocaine users and heroin users. Drug and Alcohol Dependence 2005, 77:169-175.
42. Lyons T., Chandra G., Goldstein J. Stimulant use and HIV risk behavior: the influence of peer support group participation. AIDS Education and Prevention 2006, 18:461-473.
43. Madsen K.H., Lund T.E. Filtering fMRI data by unsupervised modelling of physiological noise artifacts. Presented at the Annual Meeting of the Organization of Human Brain Mapping 2006, Florence, Italy.
44. Martin E.M., Pitrak D.L., Pursell K.J., Mullane K.M., Novak R.M. Delayed recognition memory span in HIV-1 infection. Journal of the International Neuropsychological Society 1995, 1:575-580.
45. Martin E.M., Pitrak D.L., Weddington W., Rains N.A., Nunnally G., Nixon H., Grbesic S., Vassileva J., Bechara A. Cognitive impulsivity and HIV serostatus in substance dependent males. Journal of the International Neuropsychological Society 2004, 10:931-938.
46. Mazur J.E., Coe D. Tests of transitivity in choices between fixed and variable reinforcer delays. Journal of the Experimental Analysis of Behavior 1987, 47:287-297.
47. McClure S.M., Laibson D.I., Loewenstein G., Cohen J.D. Separate neural systems value immediate and delayed monetary rewards. Science 2004, 306:503-507.
48. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment 1992, 9:199-213.
49. Melrose R.J., Tinaz S., Castelo J.M., Courtney M.G., Stern C.E. Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing. Behavioural Brain Research 2008, 188:337-347.
50. Monterosso J.R., Ainslie G., Xu J., Cordova X., Domier C.P., London E.D. Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task. Human Brain Mapping 2007, 28:383-393.
51. Petry N., Bickel W., Arnett M. Shortened time horizons and insensitivity to future consequences in heroin addicts. Addiction 1998, 93:729-738.
52. Rachlin H., Green L. Commitment, choice and self-control. Journal of the Experimental Analysis of Behavior 1972, 17:15-22.
53. Rippeth J.D., Heaton R.K., Carey C.L., Marcotte T.D., Moore D.J., Gonzalez R., Wolfson T., Grant I. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society 2004, 10:1-14.
54. SAMSHA Results from the 2007 National Survey on Drug Use and Health: National Findings 2008, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville, MD.
55. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 1998, 59:22-33.
56. Siqueland L., Crits-Christoph P., Gallop R., Barber J.P., Griffin M.L., Thase M.E., Daley D., Frank A., Gastfriend D.R., Blaine J., Connolly M.B., Gladis M. Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome. The American Journal on Addictions 2002, 11:24-40.
57. Sofuoglu M., Dudish-Poulsen S., Nelson D., Pentel P., Hatsukami D. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Experimental and Clinical Psychopharmacology 1999, 7:274-283.
58. Tanaka S., Doya K., Okada G., Ueda K., Okamoto Y., Yamawaki S. Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops. Nature Neuroscience 2004, 7:887-893.
59. Thompson P.M., Dutton R.A., Hayashi K.M., Toga A.W., Lopez O.L., Aizenstein H.J., Becker J.T. Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:15647-15652.
60. Tucker J.S., Orlando M., Burnam M.A., Sherbourne C., Kung F.-Y., Gifford A.L. Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychology 2004, 23:363-370.
61. van der Plas E.A., Crone E.A., van den Wildenberg W.P., Tranel D., Bechara A. Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women. Journal of Clinical and Experimental Neuropsychology 2009, 31:706-719.
62. Verdejo-Garcia A.J., Perales J.C., Perez-Garcia M. Cognitive impulsivity in cocaine and heroin polysubstance abusers. Addictive Behaviors 2007, 32:950-966.
63. Webber M.P., Schoenbaum E.E., Gourevitch M.N., Buono D., Klein R.S. A prospective study of HIV disease progression in female and male drug users. AIDS 1999, 13:257-262.
64. Woods S.P., Iudicello J.E., Moran L.M., Carey C.L., Dawson M.S., Grant I. HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology 2008, 22:110-117.
65. Worsley K.J., Evans A.C., Marrett S., Neelin P. A three-dimensional statistical analysis for CBF activation studies in human brain. Journal of Cerebral Blood Flow and Metabolism 1992, 12:900-918.
66. Zule W.A., Costenbader E., Coomes C.M., Meyer W.J., Riehman K., Poehlman J., Wechsberg W.M. Stimulant use and sexual risk behaviors for HIV in rural North Carolina. Journal of Rural Health 2007, 23(Suppl):73-78.